LncRNA‐ATB mediated E‐cadherin repression promotes the progression of colon cancer and predicts poor prognosis

Abstract

Long non-coding RNA-activated by TGF-β may act on colon tumorigenesis by suppressing E-cad expression and promoting EMT process, and lncRNA-ATB inhibition may provide a promising therapeutic option for suppressing colon cancer progression.